High abundance synovial fluid proteome: Distinct profiles in health and osteoarthritis

Arthritis Research and Therapy

Volumn 9, Issue , 2007, Pages

  Gobezie, Reuben ^a   Kho, Alvin ^a   Krastins, Bryan ^a   Sarracino, David A ^a   Thornhill, Thomas S ^a   Chase, Michael ^a   Millett, Peter J ^a   Lee, David M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME; BIOLOGICAL MARKER;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; ELECTROSPRAY MASS SPECTROMETRY; HEALTH; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRINCIPAL COMPONENT ANALYSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RANK SUM TEST; SEPARATION TECHNIQUE; SYNOVIAL FLUID; CHEMISTRY; CROSS-SECTIONAL STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; KNEE; METABOLISM; PATHOLOGY;

BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; KNEE; OSTEOARTHRITIS; PRINCIPAL COMPONENT ANALYSIS; PROTEOME; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SYNOVIAL FLUID;

EID: 34247847988     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2172     Document Type: Article

References (88)

1. Brooks PM Impact of osteoarthritis on individuals and society: How much disability? Social consequences and health economic implications Curr Opin Rheumatol 2002 14 573-577 10.1097/00002281-200209000-00017 12192258
2. Elders MJ The increasing impact of arthritis on public health J Rheumatol Suppl 2000 60 6-8 11032095
3. DiCesare PE Abramson SB Pathogenesis of osteoarthritis Kelley's Textbook of Rheumatology Philadelphia, PA: Elsevier/Saunders Harris ED, Ruddy S, Kelley WN 7 2005 2v (xxix, 1916, lp)
4. NCBI ftp site http://ftp.ncbi.nih.gov
5. Hung KE Kho AT Sarracino D Richard LG Krastins B Forrester S Haab BB Kohane IS Kucherlapati R Mass spectrometry-based study of the plasma proteome in a mouse intestinal tumor model J Proteome Res 2006 5 1866-1878 10.1021/pr060120r 16889408
6. Misra J Schmitt W Hwang D Hsiao LL Gullans S Stephanopoulos G Stephanopoulos G Interactive exploration of microarray gene expression patterns in a reduced dimensional space Genome Res 2002 12 1112-1120 186614 12097349 10.1101/gr.225302
7. Kho AT Zhao Q Cai Z Butte AJ Kim JY Pomeroy SL Rowitch DH Kohane IS Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers Genes Dev 2004 18 629-640 387239 15075291 10.1101/gad.1182504
8. Alter O Brown PO Botstein D Singular value decomposition for genome-wide expression data processing and modeling Proc Natl Acad Sci USA 2000 97 10101-10106 27718 10963673 10.1073/pnas.97.18.10101
9. Hollander M Wolfe DA Nonparametric Statistical Methods New York: Wiley 2 1999
10. Rhee DK Marcelino J Al-Mayouf S Schelling DK Bartels CF Cui Y Laxer R Goldbach-Mansky R Warman ML Consequences of disease-causing mutations on lubricin protein synthesis, secretion, and post-translational processing J Biol Chem 2005 280 31325-31332 10.1074/jbc.M505401200 16000300
11. Rhee DK Marcelino J Baker M Gong Y Smits P Lefebvre V Jay GD Stewart M Wang H Warman ML Carpten JD The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth J Clin Invest 2005 115 622-631 548698 15719068 10.1172/JCI200522263
12. Wu CC MacCoss MJ Howell KE Yates JR 3rd A method for the comprehensive proteomic analysis of membrane proteins Nat Biotechnol 2003 21 532-538 10.1038/nbt819 12692561
13. Washburn MP Ulaszek RR Yates JR 3rd Reproducibility of quantitative proteomic analyses of complex biological mixtures by multidimensional protein identification technology Anal Chem 2003 75 5054-5061 10.1021/ ac034120b 14708778
14. Chen EI Hewel J Felding-Habermann B Yates JR 3rd Large scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (MudPIT) Mol Cell Proteomics 2006 5 53-56 10.1074/mcp.T500013-MCP200 16272560
15. Pratta MA Su JL Leesnitzer MA Struglics A Larsson S Lohmander LS Kumar S Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments Osteoarthritis Cartilage 2006 14 702-713 10.1016/j.joca.2006.01.012 16549371
16. Struglics A Larsson S Pratta MA Kumar S Lark MW Lohmander LS Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments Osteoarthritis Cartilage 2006 14 101-113 10.1016/j.joca.2005.07.018 16188468
17. Poole AR Ionescu M Swan A Dieppe PA Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis J Clin Invest 1994 94 25-33 296278 7518830
18. Lohmander LS Ionescu M Jugessur H Poole AR Changes in joint cartilage aggrecan after knee injury and in osteoarthritis Arthritis Rheum 1999 42 534-544 10.1002/1529-0131(199904)42:3<534::AID-ANR19>3.0.CO;2-J 10088777
19. Rizkalla G Reiner A Bogoch E Poole AR Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease J Clin Invest 1992 90 2268-2277 443378 1281828
20. Chambers MG Kuffner T Cowan SK Cheah KS Mason RM Expression of collagen and aggrecan genes in normal and osteoarthritic murine knee joints Osteoarthritis Cartilage 2002 10 51-61 10.1053/joca.2001.0481 11795983
21. Morko JP Soderstrom M Saamanen AM Salminen HJ Vuorio EI Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis Ann Rheum Dis 2004 63 649-655 10.1136/ ard.2002.004671 15140771
22. Gabrijelcic D Annan-Prah A Rodic B Rozman B Cotic V Turk V Determination of cathepsins B and H in sera and synovial fluids of patients with different joint diseases J Clin Chem Clin Biochem 1990 28 149-153 2329322
23. Lenarcic B Gabrijelcic D Rozman B Drobnic-Kosorok M Turk V Human cathepsin B and cysteine proteinase inhibitors (CPIs) in inflammatory and metabolic joint diseases Biol Chem Hoppe Seyler 1988 369 Suppl 257-261 3264507
24. Martel-Pelletier J Cloutier JM Pelletier JP Cathepsin B and cysteine protease inhibitors in human osteoarthritis J Orthop Res 1990 8 336-344 10.1002/jor.1100080305 2324852
25. Abrahamson M Alvarez-Fernandez M Nathanson CM Cystatins Biochem Soc Symp 2003 70 179-199 14587292
26. Hou WS Li W Keyszer G Weber E Levy R Klein MJ Gravallese EM Goldring SR Bromme D Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium Arthritis Rheum 2002 46 663-674 10.1002/art.10114 11920402
27. Dodds RA Connor JR Drake FH Gowen M Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues Arthritis Rheum 1999 42 1588-1593 10.1002/ 1529-0131(199908)42:8<1588::AID-ANR4>3.0.CO;2-S 10446855
28. Schittek B Hipfel R Sauer B Bauer J Kalbacher H Stevanovic S Schirle M Schroeder K Blin N Meier F Garbe C Dermcidin: A novel human antibiotic peptide secreted by sweat glands Nat Immunol 2001 2 1133-1137 10.1038/ ni732 11694882
29. Rieg S Seeber S Steffen H Humeny A Kalbacher H Stevanovic S Kimura A Garbe C Schittek B Generation of multiple stable dermcidin-derived antimicrobial peptides in sweat of different body sites J Invest Dermatol 2006 126 354-365 10.1038/sj.jid.5700041 16374474
30. Ruiz-Romero C Lopez-Armada MJ Blanco FJ Proteomic characterization of human normal articular chondrocytes: A novel tool for the study of osteoarthritis and other rheumatic diseases Proteomics 2005 5 3048-3059 10.1002/pmic.200402106 16035116
31. Ruiz-Romero C Lopez-Armada MJ Blanco FJ Mitochondrial proteomic characterization of human normal articular chondrocytes Osteoarthritis Cartilage 2006 14 507-518 10.1016/j.joca.2005.12.004 16520066
32. Yoshida K Suzuki Y Saito A Fukuda K Hamanishi C Munakata H Aggrecanase-1 (ADAMTS-4) interacts with alpha1-antitrypsin Biochim Biophys Acta 2005 1725 152-159 16099106
33. Fischer DC Siebertz B van de Leur E Schiwy-Bochat KH Graeve L Heinrich PC Haubeck HD Induction of alpha1-antitrypsin synthesis in human articular chondrocytes by interleukin-6-type cytokines: Evidence for a local acute-phase response in the joint Arthritis Rheum 1999 42 1936-1945 10.1002/1529-0131(199909)42:9<1936::AID-ANR20>3.0.CO;2-K 10513810
34. Beatty K Bieth J Travis J Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin J Biol Chem 1980 255 3931-3934 6989830
35. Belcher C Fawthrop F Bunning R Doherty M Plasminogen activators and their inhibitors in synovial fluids from normal, osteoarthritis, and rheumatoid arthritis knees Ann Rheum Dis 1996 55 230-236 1010143 8733439
36. Kummer JA Abbink JJ de Boer JP Roem D Nieuwenhuys EJ Kamp AM Swaak TJ Hack CE Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseases Arthritis Rheum 1992 35 884-893 10.1002/art.1780350806 1379429
37. Saxne T Lecander I Geborek P Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis J Rheumatol 1993 20 91-96 8441174
38. Brommer EJ Dooijewaard G Dijkmans BA Breedveld FC Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation Thromb Haemost 1992 68 180-184 1412164
39. Busso N Peclat V So A Sappino AP Plasminogen activation in synovial tissues: Differences between normal, osteoarthritis, and rheumatoid arthritis joints Ann Rheum Dis 1997 56 550-557 1752434 9370880
40. Murphy G Atkinson S Ward R Gavrilovic J Reynolds JJ The role of plasminogen activators in the regulation of connective tissue metalloproteinases Ann NY Acad Sci 1992 667 1-12 10.1111/ j.1749-6632.1992.tb51590.x 1339240
41. Philip A Bostedt L Stigbrand T O'Connor-McCourt MD Binding of transforming growth factor-beta (TGF-beta) to pregnancy zone protein (PZP). Comparison to the TGF-beta-alpha 2-macroglobulin interaction Eur J Biochem 1994 221 687-693 10.1111/j.1432-1033.1994.tb18781.x 7513640
42. Clemmons DR Busby WH Jr Garmong A Schultz DR Howell DS Altman RD Karr R Inhibition of insulin-like growth factor binding protein 5 proteolysis in articular cartilage and joint fluid results in enhanced concentrations of insulin-like growth factor 1 and is associated with improved osteoarthritis Arthritis Rheum 2002 46 694-703 10.1002/ art.10222 11920405
43. Lee DM Kiener HP Brenner MB Synoviocytes Kelley's Textbook of Rheumatology Philadelphia, PA: Elsevier/Saunders Harris ED, Ruddy S, Kelley WN 7 2005 2v (xxix, 1916, lp)
44. Close DR Matrix metalloproteinase inhibitors in rheumatic diseases Ann Rheum Dis 2001 60 Suppl 3 iii62-iii67 1766680 11890658
45. Egeblad M Werb Z New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2002 2 161-174 10.1038/nrc745 11990853
46. Fassina G Ferrari N Brigati C Benelli R Santi L Noonan DM Albini A Tissue inhibitors of metalloproteases: Regulation and biological activities Clin Exp Metastasis 2000 18 111-120 10.1023/A:1006797522521 11235986
47. Wojtowicz-Praga S Torri J Johnson M Steen V Marshall J Ness E Dickson R Sale M Rasmussen HS Chiodo TA Hawkins MJ Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer J Clin Oncol 1998 16 2150-2156 9626215
48. Rasmussen HS McCann PP Matrix metalloproteinase inhibition as a novel anticancer strategy: A review with special focus on batimastat and marimastat Pharmacol Ther 1997 75 69-75 10.1016/S0163-7258(97)00023-5 9364582
49. Nemunaitis J Poole C Primrose J Rosemurgy A Malfetano J Brown P Berrington A Cornish A Lynch K Rasmussen H Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: Selection of a biologically active and tolerable dose for longer-term studies Clin Cancer Res 1998 4 1101-1109 9607566
50. Hofmann MA Drury S Fu C Qu W Taguchi A Lu Y Avila C Kambham N Bierhaus A Nawroth P RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides Cell 1999 97 889-901 10.1016/S0092-8674(00)80801-6 10399917
51. Valencia JV Mone M Zhang J Weetall M Buxton FP Hughes TE Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA Diabetes 2004 53 743-751 10.2337/diabetes.53.3.743 14988260
52. Yan SD Schmidt AM Anderson GM Zhang J Brett J Zou YS Pinsky D Stern D Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins J Biol Chem 1994 269 9889-9897 8144582
53. Lander HM Tauras JM Ogiste JS Hori O Moss RA Schmidt AM Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress J Biol Chem 1997 272 17810-17814 10.1074/jbc.272.28.17810 9211935
54. Loeser RF Yammani RR Carlson CS Chen H Cole A Im HJ Bursch LS Yan SD Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis Arthritis Rheum 2005 52 2376-2385 1488730 16052547 10.1002/art.21199
55. Huttunen HJ Fages C Rauvala H Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways J Biol Chem 1999 274 19919-19924 10.1074/ jbc.274.28.19919 10391939
56. Jerkovic L Voegele AF Chwatal S Kronenberg F Radcliffe CM Wormald MR Lobentanz EM Ezeh B Eller P Dejori N Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression J Proteome Res 2005 4 889-899 10.1021/pr0500105 15952736
57. Ricciarelli R Zingg JM Azzi A Vitamin E: Protective role of a Janus molecule FASEB J 2001 15 2314-2325 10.1096/fj.01-0258rev 11689457
58. Connor JR Kumar S Sathe G Mooney J O'Brien SP Mui P Murdock PR Gowen M Lark MW Clusterin expression in adult human normal and osteoarthritic articular cartilage Osteoarthritis Cartilage 2001 9 727-737 10.1053/ joca.2001.0475 11795992
59. Zhang H Kim JK Edwards CA Xu Z Taichman R Wang CY Clusterin inhibits apoptosis by interacting with activated Bax Nat Cell Biol 2005 7 909-915 10.1038/ncb1291 16113678
60. Worthy K Figueroa CD Dieppe PA Bhoola KD Kallikreins and kinins: mediators in inflammatory joint disease? Int J Exp Pathol 1990 71 587-601 2205284
61. Bhoola KD Elson CJ Dieppe PA Kinins: Key mediators in inflammatory arthritis? Br J Rheumatol 1992 31 509-518 10.1093/rheumatology/31.8.509 1643449
62. Pelc LR Gross GJ Warltier DC Mechanism of coronary vasodilation produced by bradykinin Circulation 1991 83 2048-2056 1645623
63. McIntyre TM Zimmerman GA Satoh K Prescott SM Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate J Clin Invest 1985 76 271-280 423763 2862164
64. Colman RW Stadnicki A Kettner CA Adam AA DeLa Cadena RA Sartor RB Activation of the kallikrein-kinin system in arthritis and enterocolitis in genetically susceptible rats: Modulation by a selective plasma kallikrein inhibitor Proc Assoc Am Physicians 1997 109 10-22 9010912
65. Sheikh IA Kaplan AP Assessment of kininases in rheumatic diseases and the effect of therapeutic agents Arthritis Rheum 1987 30 138-145 10.1002/ art.1780300203 3030335
66. Bond AP Lemon M Dieppe PA Bhoola KD Generation of kinins in synovial fluid from patients with arthropathy Immunopharmacology 1997 36 209-216 10.1016/S0162-3109(97)00023-4 9228548
67. Neumann E Barnum SR Tarner IH Echols J Fleck M Judex M Kullmann F Mountz JD Scholmerich J Gay S Muller-Ladner U Local production of complement proteins in rheumatoid arthritis synovium Arthritis Rheum 2002 46 934-945 10.1002/art.10183 11953970
68. Ruddy S Colten HR Rheumatoid arthritis. Biosynthesis of complement proteins by synovial tissues N Engl J Med 1974 290 1284-1288 4133295
69. Katz Y Strunk RC Synovial fibroblast-like cells synthesize seven proteins of the complement system Arthritis Rheum 1988 31 1365-1370 10.1002/art.1780311104 3142487
70. Firestein GS Paine MM Littman BH Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids Arthritis Rheum 1991 34 1094-1105 10.1002/art.1780340905 1657009
71. Breitner S Storkel S Reichel W Loos M Complement components C1q, C1r/ C1s, and C1INH in rheumatoid arthritis. Correlation of in situ hybridization and northern blot results with function and protein concentration in synovium and primary cell cultures Arthritis Rheum 1995 38 492-498 10.1002/art.1780380406 7718002
72. Olmez U Garred P Mollnes TE Harboe M Berntzen HB Munthe E C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis Scand J Rheumatol 1991 20 183-189 2068540
73. Collard CD Lekowski R Jordan JE Agah A Stahl GL Complement activation following oxidative stress Mol Immunol 1999 36 941-948 10.1016/ S0161-5890(99)00116-9 10698348
74. Doherty M Richards N Hornby J Powell R Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy Ann Rheum Dis 1988 47 190-197 1003482 2833185
75. Corvetta A Pomponio G Rinaldi N Luchetti MM Di Loreto C Stramazzotti D Terminal complement complex in synovial tissue from patients affected by rheumatoid arthritis, osteoarthritis and acute joint trauma Clin Exp Rheumatol 1992 10 433-438 1458695
76. Collins T Winkelstein JA Sullivan KE Regulation of early complement components C3 and C4 in the synovium Clin Diagn Lab Immunol 1996 3 5-9 170239 8770496
77. Eyre DR Wu JJ Apone S A growing family of collagens in articular cartilage: Identification of 5 genetically distinct types J Rheumatol 1987 14 Spec No 25 27 3625672
78. Swoboda B Pullig O Kirsch T Kladny B Steinhauser B Weseloh G Increased content of type-VI collagen epitopes in human osteoarthritic cartilage: quantitation by inhibition ELISA J Orthop Res 1998 16 96-99 10.1002/ jor.1100160116 9565079
79. Lohmander LS Saxne T Heinegard DK Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis Ann Rheum Dis 1994 53 8-13 1005235 8311563
80. Saxne T Glennas A Kvien TK Melby K Heinegard D Release of cartilage macromolecules into the synovial fluid in patients with acute and prolonged phases of reactive arthritis Arthritis Rheum 1993 36 20-25 10.1002/art.1780360105 7678742
81. Hedbom E Antonsson P Hjerpe A Aeschlimann D Paulsson M Rosa-Pimentel E Sommarin Y Wendel M Oldberg A Heinegard D Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage J Biol Chem 1992 267 6132-6136 1556121
82. Knudson CB Knudson W Cartilage proteoglycans Semin Cell Dev Biol 2001 12 69-78 10.1006/scdb.2000.0243 11292372
83. Jay GD Tantravahi U Britt DE Barrach HJ Cha CJ Homology of lubricin and superficial zone protein (SZP): Products of megakaryocyte stimulating factor (MSF) gene expression by human synovial fibroblasts and articular chondrocytes localized to chromosome 1q25 J Orthop Res 2001 19 677-687 10.1016/S0736-0266(00)00040-1 11518279
84. Lorenzo P Bayliss MT Heinegard D A novel cartilage protein (CILP) present in the mid-zone of human articular cartilage increases with age J Biol Chem 1998 273 23463-23468 10.1074/jbc.273.36.23463 9722583
85. Lorenzo P Neame P Sommarin Y Heinegard D Cloning and deduced amino acid sequence of a novel cartilage protein (CILP) identifies a proform including a nucleotide pyrophosphohydrolase J Biol Chem 1998 273 23469-23475 10.1074/jbc.273.36.23469 9722584
86. Martin JA Brown TD Heiner AD Buckwalter JA Chondrocyte senescence, joint loading and osteoarthritis Clin Orthop Relat Res 2004 427 Suppl S96-S103 10.1097/01.blo.0000143818.74887.b1 15480082
87. Buckwalter JA Lappin DR The disproportionate impact of chronic arthralgia and arthritis among women Clin Orthop Relat Res 2000 372 159-168 10.1097/00003086-200003000-00018 10738425
88. Buckwalter JA Mankin HJ Articular cartilage: Degeneration and osteoarthritis, repair, regeneration, and transplantation Instr Course Lect 1998 47 487-504 9571450